Summer Sale

50% off Premium Yearly

00days
00hrs
00mins
00secs
HMP.TO 0.03SPGP 1ZUQ.TO 0.55NVDA 0.32GL 1.66MRK -1.71IEMG 0.5GEV 33.87
Novelion (NVLN.TO)

Novelion (NVLN.TO)

0.00
-0.00 (0.00%)
52 watching
Icon Financials Financials Icon Analysis Technical Analysis
Interactive Chart
1w 1m 6m 1y
0
TOP PICK

Novelion(NVLN.TO)

Oct 22, 2001
Visudine should take off. Wait for a pullback before buying.
Photo of Mark Jackson, CFAMark Jackson, CFAUnlock Rating
$40.00

Stock price when the opinion was issued

biotechnologypharmaceutical
DON'T BUY

Novelion(NVLN.TO)

Oct 19, 2001
Too expensive. One product company.
Photo of Steven WipperstegSteven WipperstegUnlock Rating
$37.46

Stock price when the opinion was issued

biotechnologypharmaceutical
BUY

Novelion(NVLN.TO)

Oct 17, 2001
Good price. Should do well.
Photo of Mike WeirMike WeirUnlock Rating
$29.15

Stock price when the opinion was issued

biotechnologypharmaceutical
WAIT

Novelion(NVLN.TO)

Oct 16, 2001
Wait for their next quarter report to see if there is some growth upside or buy in the low $20's.
Photo of Glenn Paradis, BA, CFAGlenn Paradis, BA, CFAUnlock Rating
$29.60

Stock price when the opinion was issued

biotechnologypharmaceutical
DON'T BUY

Novelion(NVLN.TO)

Sep 27, 2001
One drug only. Volatile and risky.
Photo of Gordon Higgins, CA, MBAGordon Higgins, CA, MBAUnlock Rating
$24.50

Stock price when the opinion was issued

biotechnologypharmaceutical
BUY

Novelion(NVLN.TO)

Sep 24, 2001
At a good price. Great product.
Photo of Glenn Paradis, BA, CFAGlenn Paradis, BA, CFAUnlock Rating
$25.05

Stock price when the opinion was issued

biotechnologypharmaceutical
DON'T BUY

Novelion(NVLN.TO)

Aug 30, 2001
Have to have a 3/4 year outlook.
Photo of Joe ConnollyJoe ConnollyUnlock Rating
$30.15

Stock price when the opinion was issued

biotechnologypharmaceutical
BUY

Novelion(NVLN.TO)

Aug 29, 2001
Will perform with biotech sector. Long term will do very well.
Photo of John Sinkins, CFAJohn Sinkins, CFAUnlock Rating
$30.99

Stock price when the opinion was issued

biotechnologypharmaceutical
TOP PICK

Novelion(NVLN.TO)

Aug 24, 2001
Expects health services to lead the market. New product to cure macular degeneration.
Photo of Martin Hubbes, CFAMartin Hubbes, CFAUnlock Rating
$33.15

Stock price when the opinion was issued

biotechnologypharmaceutical
BUY

Novelion(NVLN.TO)

Aug 24, 2001
Got ahead of itself last year, but more reasonable now. Real company with real earnings. Still expensive.
Photo of Gavin GrahamGavin GrahamUnlock Rating
$33.15

Stock price when the opinion was issued

biotechnologypharmaceutical
BUY

Novelion(NVLN.TO)

Aug 15, 2001
Has great potential. Hold for the long term.
Photo of Mike WeirMike WeirUnlock Rating
$33.20

Stock price when the opinion was issued

biotechnologypharmaceutical
DON'T BUY

Novelion(NVLN.TO)

Aug 10, 2001
Good product, but only a one product company.
Photo of Steven WipperstegSteven WipperstegUnlock Rating
$32.61

Stock price when the opinion was issued

biotechnologypharmaceutical
PAST TOP PICK

Novelion(NVLN.TO)

Jul 31, 2001
(Was a top pick on Jun 13/01 up 5%) Still likes
Photo of Ted MacklinTed MacklinUnlock Rating
$32.26

Stock price when the opinion was issued

biotechnologypharmaceutical
TOP PICK

Novelion(NVLN.TO)

Jul 11, 2001
Good products.
Photo of Martin Hubbes, CFAMartin Hubbes, CFAUnlock Rating
$29.40

Stock price when the opinion was issued

biotechnologypharmaceutical
BUY

Novelion(NVLN.TO)

Jul 06, 2001
Looking attractive now. Volatile.
Photo of Glenn Paradis, BA, CFAGlenn Paradis, BA, CFAUnlock Rating
$29.96

Stock price when the opinion was issued

biotechnologypharmaceutical
Showing 136 to 150 of 190 entries

Build your watch list

Sign in to track investments
you care about

Latest Buy Signals

EPD -0.03$37.25
ET 0.31$19.07
MAIR 0$
RKLB -12.39$102.39
SESG-O 0$
The ultimate 360° Tracker Your financial life in one place, automaticallywealthica-video

Today's Top Picks

HMP.TO 0.03$9.75
SPGP 1$120.39
ZUQ.TO 0.55$107.47
NVDA 0.32$205.19
GL 1.66$166.76

Popular Articles

Latest Sell Signals

PRGO 0.09$10.99
CBRS 0$
HAWK 0$
AVEX 0$
SWMR 0$

Most Recent Experts

Jim Cramer - Mad Money

Jim Cramer - Mad Money

CNBC

Richard Orrell

Richard Orrell

RN Croft Financial Group

Stockchase Insights

Stockchase Insights

5i Research

The Panic-Proof Portfolio (Stockchase Research)

The Panic-Proof Portfolio (Stockchase Research)

Stockchase Premium

Stan Wong

Stan Wong

Private Wealth Management, ScotiaMcleod

disclaimer

Stockchase, in its reporting on what has been discussed by individuals on business television programs (in particular Business News Network), neither recommends nor promotes any investment strategies.

We paraphrase the experts by hand, we watch the shows and write down what we understood from the experts’ comments. We are human and can make mistakes, help us fix any errors. If you see something that you know is not right or if there is a problem with the site, feel free to email us at: [email protected].

About usHow to useContact Us
More...
AdvertisingIn the newsPrivacy PolicyTerms of service
FacebookX
© 2000 - 2026 Stockchase Inc. by Wealthica
The ultimate 360° Tracker Your financial life in one place, automaticallywealthica-video